— Know what they know.
Not Investment Advice

RNGE OTC

Range Impact, Inc.
1W: -8.7% 1M: -10.6% 3M: +4.5% YTD: +350.2% 1Y: +226.1% 3Y: +328.0% 5Y: +107.5%
$0.68
-0.01 (-0.81%)
 
Weekly Expected Move ±7.9%
$1 $1 $1 $1 $1
OTC · Basic Materials · Industrial Materials · Tech Score Sell · Power 43 · $81.9M mcap · 75M float · 0.061% daily turnover · Short 23% of daily vol

Balance Sheet Trends

Total Assets
$6M -74.0% ▼
5Y CAGR: +0.4%
Total Liabilities
$5M -62.3% ▼
5Y CAGR: +38.4%
Shareholders Equity
$834K -91.3% ▼
5Y CAGR: -30.2%
Cash & Investments
$167K -92.3% ▼
5Y CAGR: -51.1%
Total Debt
$5M -55.8% ▼
Net Debt
$4M -46.1% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2022FY2023FY2024
— Assets —
Cash$2M$884K$442K$2M$167K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$2M$884K$442K$2M$167K
Net Receivables$0$0$981K$7M$3M
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$734K
Total Current Assets$2M$887K$1M$10M$4M
Property, Plant & Equip.$124K$0$6M$13M$2M
Goodwill & Intangibles$0$0$751K$751K$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$36K$10K$9K$10K$0
Total Non-Current Assets$159K$10K$7M$14M$2M
Total Assets$3M$897K$8M$24M$6M
— Liabilities —
Accounts Payable$863K$0$234K$4M$557K
Short-Term Debt$0$0$1M$5M$3M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$297K$33K$0$0$0
Total Current Liabilities$1M$33K$2M$9M$4M
Long-Term Debt$0$0$4M$5M$2M
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$4M$5M$2M
Total Liabilities$1M$33K$5M$14M$5M
— Equity —
Common Stock$51K$51K$78K$101K$105K
Retained Earnings-$47M-$47M-$50M-$47M-$57M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$1M$863K$3M$10M$834K
Total Liabilities & Equity$3M$897K$8M$24M$6M
— Key Metrics —
Total Debt$126K$0$5M$10M$5M
Net Debt-$2M-$884K$5M$8M$4M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms